JiangXi Tianxin Pharmaceutical Co., Ltd. (SHA:603235)
China · Delayed Price · Currency is CNY 24.70
-0.46 (-1.83%)
At close: Sep 14, 2026
SHA:603235 Balance Sheet
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Assets
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Equivalents | 1,692 | 1,570 | 1,078 | 2,308 | 2,070 | 717.08 |
Trading Asset Securities | 116.68 | - | 481.69 | - | 230 | - |
Cash & Short-Term Investments | 1,808 | 1,570 | 1,560 | 2,308 | 2,300 | 717.08 |
Cash Growth | 21.32% | 0.62% | -32.40% | 0.35% | 220.73% | -29.65% |
Accounts Receivable | 451.08 | 460.26 | 414.28 | 284.34 | 357.31 | 418.96 |
Other Receivables | 6.99 | 3.03 | 1.4 | 1.7 | 2.03 | 2.23 |
Receivables | 458.07 | 463.29 | 415.68 | 286.05 | 359.35 | 421.19 |
Inventory | 684.88 | 569.89 | 589.23 | 478.97 | 470.63 | 405.54 |
Other Current Assets | 72.13 | 179.98 | 130.46 | 48.47 | 36.4 | 35.58 |
Total Current Assets | 3,024 | 2,783 | 2,695 | 3,121 | 3,166 | 1,579 |
Property, Plant & Equipment | 3,108 | 3,104 | 2,585 | 1,618 | 1,311 | 1,183 |
Long-Term Investments | - | - | - | 0.03 | 0.4 | - |
Other Intangible Assets | 186.42 | 188.48 | 188.16 | 192.31 | 109.81 | 111.8 |
Long-Term Deferred Tax Assets | 90.59 | 90.9 | 83.18 | 81.13 | 58.6 | 61.46 |
Long-Term Deferred Charges | 16.26 | 14.73 | 9.61 | 10.99 | 12.38 | 4.04 |
Other Long-Term Assets | 16.32 | 8.34 | 42.11 | 66.05 | 21.95 | 12.45 |
Total Assets | 6,442 | 6,190 | 5,603 | 5,090 | 4,680 | 2,952 |
Liabilities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Accounts Payable | 247.88 | 312.22 | 250.13 | 138.07 | 108.55 | 121.11 |
Accrued Expenses | 69.45 | 143.55 | 125.76 | 115.86 | 112.97 | 100.66 |
Short-Term Debt | 133.73 | 7.33 | 16.06 | 100.07 | - | 300.3 |
Current Portion of Long-Term Debt | - | 83.67 | 10.1 | - | - | 14.02 |
Current Portion of Leases | 77.76 | 0.91 | 3.28 | 3.12 | 3.42 | 3.33 |
Current Income Taxes Payable | 35.17 | 24.54 | 23.45 | 30.68 | 0.5 | 49.01 |
Current Unearned Revenue | 17.08 | 18.29 | 24.02 | 21.1 | 23.34 | 19.71 |
Other Current Liabilities | 268.6 | 45.08 | 56.98 | 52.42 | 62.4 | 68.92 |
Total Current Liabilities | 849.68 | 635.59 | 509.78 | 461.33 | 311.18 | 677.06 |
Long-Term Debt | 273.49 | 299.84 | 117.43 | - | - | 26.04 |
Long-Term Leases | 12.56 | 13.18 | 1.82 | 5.1 | 4.65 | 7.98 |
Long-Term Unearned Revenue | 309.28 | 324.6 | 358.37 | 390.79 | 306.16 | 332.49 |
Total Liabilities | 1,445 | 1,273 | 987.41 | 857.21 | 621.98 | 1,044 |
Shareholders' Equity
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Common Stock | 437.78 | 437.78 | 437.78 | 437.78 | 437.78 | 394 |
Additional Paid-In Capital | 2,002 | 2,002 | 1,997 | 1,987 | 1,977 | 493.58 |
Retained Earnings | 2,617 | 2,537 | 2,241 | 1,808 | 1,643 | 1,021 |
Treasury Stock | -60.01 | -60.01 | -60.01 | - | - | - |
Shareholders' Equity | 4,996 | 4,917 | 4,616 | 4,233 | 4,058 | 1,909 |
Total Liabilities & Equity | 6,442 | 6,190 | 5,603 | 5,090 | 4,680 | 2,952 |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Total Debt | 497.54 | 404.92 | 148.69 | 108.29 | 8.07 | 351.68 |
Net Cash (Debt) | 1,311 | 1,165 | 1,411 | 2,200 | 2,292 | 365.41 |
Net Cash Growth | 13.97% | -17.47% | -35.84% | -4.03% | 527.19% | -45.78% |
Net Cash Per Share | 2.98 | 2.66 | 3.23 | 5.04 | 5.56 | 0.93 |
Filing Date Shares Outstanding | 442.5 | 435.17 | 435.17 | 436.41 | 437.78 | 394 |
Total Common Shares Outstanding | 442.5 | 435.17 | 435.17 | 437.78 | 437.78 | 394 |
Working Capital | 2,174 | 2,147 | 2,186 | 2,660 | 2,855 | 902.34 |
Book Value Per Share | 11.29 | 11.30 | 10.61 | 9.67 | 9.27 | 4.84 |
Tangible Book Value | 4,810 | 4,728 | 4,428 | 4,041 | 3,948 | 1,797 |
Tangible Book Value Per Share | 10.87 | 10.86 | 10.17 | 9.23 | 9.02 | 4.56 |
Buildings | - | 1,287 | 847.28 | 655.11 | 596.5 | 552.3 |
Machinery | - | 1,860 | 1,499 | 1,257 | 1,189 | 1,056 |
Construction In Progress | - | 1,007 | 1,117 | 435.37 | 122.64 | 51.69 |